Eastwood GL, Beck BD, Castell DO, Brown FC, Fletcher JR
Despite promising Phase 2 results and an excellent safety profile, the compound could not demonstrate sufficient efficacy in the larger confirmatory trial to justify the investment required for continued pharmaceutical development toward regulatory approval
It shows up alongside GHK-Cu and BPC-157 because all three are categorized as regenerative peptides in the biohacking community
BPC 157/TB 500 (The Wolverine of Healing) Benefits of BPC 157/TB 500 TB-500 (Tissue Regeneration/Mobility Enhancement) Stimulates Cell Growth & Regeneration Aids in muscle, tendon, and ligament repair
As research continues and more patients benefit from tirzepatide, staying informed and connected to healthcare professionals will be essential for optimizing outcomes and maintaining quality of life
Answer: Technically possible